SEC Form 4 · accession 0001144204-19-002890
Checkpoint Therapeutics, Inc. · CKPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James F Oliviero III
Officer — CEO, President and Director · Director
Period of report
Jan 24, 2019
Accepted (ET)
Jan 25, 2019 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK (RESTRICTED)F1,F2 | Jan 24, 2019 | A | 485,000 | $0.00 | A | 2,135,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of restricted stock vest as follows: one-half on January 24, 2021, one-fourth on January 24, 2022 and one-fourth on January 24, 2023.
- F2Includes 1,000,000 shares of restricted stock that were granted on October 13, 2015, 325,000 shares of restricted stock that were granted on December 15, 2016, and 325,000 shares of restricted stock that were granted on January 30, 2018, all previously reported.